Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation

Cellular Immunology

Volumn 288, Issue 1-2, 2014, Pages 53-59

  Kato, Tomonori ^a   Nishida, Tetsuya ^a   Ito, Yoshinori ^a   Murase, Miho ^a   Murata, Makoto ^a   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Cytomegalovirus specific T cell; Exhaustion; IL 6; Programmed death 1

Indexed keywords

CD33 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOMEGALOVIRUS ANTIGEN PP65; FLUDARABINE; FOSCARNET; GANCICLOVIR; HLA A ANTIGEN; INTERLEUKIN 6; METHOTREXATE; METHYLPREDNISOLONE; PROGRAMMED DEATH 1 LIGAND 1; TACROLIMUS;

ADHERENT CELL; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL GROWTH; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MANTLE CELL LYMPHOMA; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; VIRAL CLEARANCE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS-SPECIFIC T CELL; EXHAUSTION; IL-6; PROGRAMMED DEATH 1;

CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL COMMUNICATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-A24 ANTIGEN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-6; MALE; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; SIALIC ACID BINDING IG-LIKE LECTIN 3; SIGNAL TRANSDUCTION; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD;

EID: 84896526870     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.02.007     Document Type: Article

References (40)

1. Boeckh M., Leisenring W., Riddell S.R., Bowden R.A., Huang M.L., Myerson D., Stevens-Ayers T., Flowers M.E., Cunningham T., Corey L. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003, 101:407-414.
2. Boeckh M., Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009, 113:5711-5719.
3. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 1995, 333:1038-1044.
4. Peggs K.S., Verfuerth S., Pizzey A., Khan N., Guiver M., Moss P.A., Mackinnon S. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 2003, 362:1375-1377.
5. Einsele H., Roosnek E., Rufer N., Sinzger C., Riegler S., Loffler J., Grigoleit U., Moris A., Rammensee H.G., Kanz L., Kleihauer A., Frank F., Jahn G., Hebart H. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002, 99:3916-3922.
6. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., Mackey E.W., Miller J.D., Leslie A.J., DePierres C., Mncube Z., Duraiswamy J., Zhu B., Eichbaum Q., Altfeld M., Wherry E.J., Coovadia H.M., Goulder P.J., Klenerman P., Ahmed R., Freeman G.J., Walker B.D. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
7. + T cells leads to reversible immune dysfunction. Nat. Med. 2006, 12:1198-1202.
8. + T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007, 109:4671-4678.
9. + T lymphocytes in the liver. J. Immunol. 2007, 178:2714-2720.
10. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 2009, 10:29-37.
11. Gallez-Hawkins G.M., Thao L., Palmer J., Dagis A., Li X., Franck A.E., Tegtmeier B., Lacey S.F., Diamond D.J., Forman S.J., Zaia J.A. Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 2009, 15:872-880.
12. Kinter A.L., Godbout E.J., McNally J.P., Sereti I., Roby G.A., O'Shea M.A., Fauci A.S. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J. Immunol. 2008, 181:6738-6746.
13. Asemissen A.M., Nagorsen D., Keilholz U., Letsch A., Schmittel A., Thiel E., Scheibenbogen C. Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells. J. Immunol. Methods 2001, 251:101-108.
14. Becker C., Pohla H., Frankenberger B., Schuler T., Assenmacher M., Schendel D.J., Blankenstein T. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Nat. Med. 2001, 7:1159-1162.
15. + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:7875-7880.
16. Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell 2009, 138:30-50.
17. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
18. Serriari N.E., Gondois-Rey F., Guillaume Y., Remmerswaal E.B., Pastor S., Messal N., Truneh A., Hirsch I., van Lier R.A., Olive D. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J. Immunol. 2010, 185:3140-3148.
19. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., Galli S.J. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 2006, 176:2238-2248.
20. + T cell activation during HIV infection. Nat. Med. 2010, 16:452-459.
21. Chen X., Das R., Komorowski R., Beres A., Hessner M.J., Mihara M., Drobyski W.R. Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood 2009, 114:891-900.
22. + T cells. J. Exp. Med. 2008, 205:1019-1027.
23. Serada S., Fujimoto M., Mihara M., Koike N., Ohsugi Y., Nomura S., Yoshida H., Nishikawa T., Terabe F., Ohkawara T., Takahashi T., Ripley B., Kimura A., Kishimoto T., Naka T. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9041-9046.
24. Diao J., Zhao J., Winter E., Cattral M.S. Tumors suppress in situ proliferation of cytotoxic T cells by promoting differentiation of Gr-1(+) conventional dendritic cells through IL-6. J. Immunol. 2011, 186:5058-5067.
25. Kishimoto T. IL-6: from its discovery to clinical applications. Int. Immunol. 2010, 22:347-352.
26. Chomarat P., Banchereau J., Davoust J., Palucka A.K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 2000, 1:510-514.
27. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 2004, 4:941-952.
28. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 2009, 182:4499-4506.
29. Park S.J., Nakagawa T., Kitamura H., Atsumi T., Kamon H., Sawa S., Kamimura D., Ueda N., Iwakura Y., Ishihara K., Murakami M., Hirano T. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 2004, 173:3844-3854.
30. Kitamura H., Kamon H., Sawa S., Park S.J., Katunuma N., Ishihara K., Murakami M., Hirano T. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity 2005, 23:491-502.
31. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
32. + T cell tolerance in cancer. Nat. Med. 2007, 13:828-835.
33. Tacke R.S., Lee H.C., Goh C., Courtney J., Polyak S.J., Rosen H.R., Hahn Y.S. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 2012, 55:343-353.
34. Cripps J.G., Gorham J.D. MDSC in autoimmunity. Int. Immunopharmacol. 2011, 11:789-793.
35. Lechner M.G., Liebertz D.J., Epstein A.L. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 2010, 185:2273-2284.
36. Sinclair J. Human cytomegalovirus: latency and reactivation in the myeloid lineage. J. Clin. Virol. 2008, 41:180-185.
37. + monocytes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20039-20044.
38. Ogata M., Satou T., Kawano R., Takakura S., Goto K., Ikewaki J., Kohno K., Ikebe T., Ando T., Miyazaki Y., Ohtsuka E., Saburi Y., Saikawa T., Kadota J. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant. 2010, 45:129-136.
39. Mauray S., Fuzzati-Armentero M.T., Trouillet P., Ruegg M., Nicoloso G., Hart M., Aarden L., Schapira M., Duchosal M.A. Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6. Eur. J. Immunol. 2000, 30:2065-2073.
40. Hohaus S., Santangelo R., Giachelia M., Vannata B., Massini G., Cuccaro A., Martini M., Cesarini V., Cenci T., D'Alo F., Voso M.T., Fadda G., Leone G., Larocca L.M. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Clin. Cancer Res. 2011, 17:2885-2892.